{"version":"1.0","provider_name":"CIMTI.cat - Centre per a la Integraci\u00f3 de la Medicina i les Tecnologies Innovadores","provider_url":"https:\/\/cimti.cat\/ca","author_name":"CIMTI","author_url":"https:\/\/cimti.cat\/ca\/author\/elisenda\/","title":"Interview of Oliver Ballcells, RheODx, in Sifted - CIMTI.cat - Centre per a la Integraci\u00f3 de la Medicina i les Tecnologies Innovadores","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"orNXqmeLRY\"><a href=\"https:\/\/cimti.cat\/ca\/interview-of-oliver-ballcells-rheodx-in-sifted\/\">Interview of Oliver Ballcells, RheODx, in Sifted<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/cimti.cat\/ca\/interview-of-oliver-ballcells-rheodx-in-sifted\/embed\/#?secret=orNXqmeLRY\" width=\"600\" height=\"338\" title=\"&#8220;Interview of Oliver Ballcells, RheODx, in Sifted&#8221; &#8212; CIMTI.cat - Centre per a la Integraci\u00f3 de la Medicina i les Tecnologies Innovadores\" data-secret=\"orNXqmeLRY\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/*! This file is auto-generated *\/\n!function(c,d){\"use strict\";var e=!1,o=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},c.wp.receiveEmbedMessage);else if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(!t);else if(!(t.secret||t.message||t.value));else if(\/[^a-zA-Z0-9]\/.test(t.secret));else{for(var r,s,a,i=d.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),n=d.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),o=new RegExp(\"^https?:$\",\"i\"),l=0;l<n.length;l++)n[l].style.display=\"none\";for(l=0;l<i.length;l++)if(r=i[l],e.source!==r.contentWindow);else{if(r.removeAttribute(\"style\"),\"height\"===t.message){if(1e3<(s=parseInt(t.value,10)))s=1e3;else if(~~s<200)s=200;r.height=s}if(\"link\"===t.message)if(s=d.createElement(\"a\"),a=d.createElement(\"a\"),s.href=r.getAttribute(\"src\"),a.href=t.value,!o.test(a.protocol));else if(a.host===s.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener(\"message\",c.wp.receiveEmbedMessage,!1),d.addEventListener(\"DOMContentLoaded\",t,!1),c.addEventListener(\"load\",t,!1);function t(){if(o);else{o=!0;for(var e,t,r,s=-1!==navigator.appVersion.indexOf(\"MSIE 10\"),a=!!navigator.userAgent.match(\/Trident.*rv:11\\.\/),i=d.querySelectorAll(\"iframe.wp-embedded-content\"),n=0;n<i.length;n++){if(!(r=(t=i[n]).getAttribute(\"data-secret\")))r=Math.random().toString(36).substr(2,10),t.src+=\"#?secret=\"+r,t.setAttribute(\"data-secret\",r);if(s||a)(e=t.cloneNode(!0)).removeAttribute(\"security\"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:\"ready\",secret:r},\"*\")}}}}(window,document);\n<\/script>\n","description":"Theranos failed hard, but did it also prove the market?\u00a0Meet de founders building blood test startups in a post-Theranos world.\u00a0 &nbsp; Oliver Balcells Navarro, RheoDX (\u20ac350K raised) RheoDX was founded in Barcelona, Spain, in 2018, and has already won awards from the European Commission. It raised \u20ac350K this year on Spanish investment platform Capital Cell [&hellip;]"}